Key facts
- It has raised $1.4M across 2 recorded rounds; the latest was Seed Round ($405K) in Feb 2023.
- Notable investors include Creative Destruction Lab, US National Science Foundation, MedTech Innovator, Springboard Enterprises, Tampa Bay Wave — 22 tracked in total.
- Winter Innovations has filed 5 Form Ds with the SEC since 2019, most recently Mar 2023 ($405K sold to 19 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Winter Innovations
Funding rounds
2 roundsAbout Winter Innovations
Developer of medical devices designed for orthopedic ligament and tendon reconstruction surgery. The company's suturing needle is designed to simplify and standardize whip stitching and offers the benefits of ease of use, speed, stability, and versatility, enabling surgeons to improve the speed and consistency of orthopedic reconstruction procedures.
- Industry
- Surgical Devices
- Sector
- Healthcare
- HQ
- Knoxville, TN, United States
- Founded
- 2018
- Employees
- 6
- Website
- winter-innovations.com/
- Ownership
- Privately Held (backing)
Winter Innovations doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Winter Innovations shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Winter Innovations in its N-PORT filings yet. We sweep new filings monthly.